Keflex (Cefalexin)
cefalexin 500 mg capsule, 20 · ORAL · PBS code 11934D
STREAMLINEDWhat it costs
AU$2.5 PBS-determined price per 40 units
Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.
- • First listed on the PBS: 2020-04-01.
- • Repeats: 0.
- • PBS program: GE.
Eligibility criteria for subsidised access
The following is the government's own wording from the PBS Schedule, shown unchanged.
Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1
Infection
Patient must have a pin-site infection; or
Patient must have an infection following cardiac device insertion; or
Patient must have acute otitis externa; or
Patient must have streptococcal pharyngitis or tonsillitis; or
Patient must have mastitis; or
Patient must have periorbital (preseptal) cellulitis; or
Patient must have acute rheumatic fever; or
Patient must have a diabetic foot infection; or
Patient must have a widespread infection of dermatitis; or
Patient must require treatment for prophylaxis for invasive group A streptococcal (iGAS) infection; or
Patient must have impetigo; or
Patient must have pyelonephritis; or
Patient must have a condition requiring prolonged oral antibiotic therapy.
Midwives may prescribe under this item for the treatment of mastitis only.
Sponsor: Aspen Pharmacare Australia Pty Limited ABN 51 096 236 985
Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.
Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.